Skip to main content
logo
Chordia Therapeutics Inc. (TYO:190A)
Japan flag Japan · Delayed Price · Currency is JPY
72.00
-2.00 (-2.70%)
Aug 27, 2026, 3:30 PM JST

Chordia Therapeutics Ratios and Metrics

Millions JPY. Fiscal year is Sep - Aug.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023
Period Ending
Aug '26 Aug '25 Aug '24 Aug '23
Market Capitalization
5,71712,41851,534-
Market Cap Growth
-55.45%-75.90%--
Enterprise Value
3,2119,59648,276-
Last Close Price
74.00180.00780.00-

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023
Period Ending
Aug '26 Aug '25 Aug '24 Aug '23
PB Ratio
2.455.1012.38-
P/TBV Ratio
2.455.1012.39-

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023
Period Ending
Aug '26 Aug '25 Aug '24 Aug '23
Net Debt / Equity Ratio
-1.07-1.05-1.04-1.07
Net Debt / EBITDA Ratio
1.741.432.41-22.00
Net Debt / FCF Ratio
-1.382.23-8.83
Quick Ratio
9.9210.439.1911.76
Current Ratio
10.1810.929.7811.98
Return on Equity (ROE)
-55.63%-54.13%-42.19%-
Return on Assets (ROA)
-32.30%-30.59%-23.60%-
Return on Capital Employed (ROCE)
-61.70%-73.40%-43.30%4.70%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023
Period Ending
Aug '26 Aug '25 Aug '24 Aug '23
Earnings Yield
-25.09%-14.38%-3.55%-
FCF Yield
-23.41%-14.84%-3.76%-
Buyback Yield / Dilution
-5.73%-16.82%-4.05%-